Clinical Trial

A Phase II Study of QLS12010 Capsules in Adults With Moderate to Severe Atopic Dermatitis

Name: A Phase II Study of QLS12010 Capsules in Adults With Moderate to Severe Atopic Dermatitis — clinical trial record (NCT07344051)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

This trial was designed to evaluate the efficacy and safety of QLS12010 Capsules in adults with moderate-to-severe atopic dermatitis.

Trial Details

NCT Number	NCT07344051
Lead Sponsor	Qilu Pharmaceutical Co., Ltd.
Conditions	Moderate-to-severe Atopic Dermatitis
Enrollment	160 participants
Start Date	2026-04-05
Primary Completion	2027-09 (estimated)
Study Completion	2027-09 (estimated)
Updated on ClinicalTrials.gov	2026-01-15